http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104788427-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104788427-B |
| titleOfInvention | 3 (2 pyrimdinyl-amino) phenylacryloyl amine compounds and its application |
| abstract | The invention discloses 3 (2 pyrimdinyl-amino) the phenylacryloyl amine compounds or its salt for pharmaceutically receiving or stereoisomer or prodrugs of a kind of formula (I) structure.Compound of the present invention or its salt for pharmaceutically receiving, the growth of kinds of tumor cells can effectively be suppressed, and inhibitory action is produced to other protease of EGFR, Her family, can be used to prepare antineoplastic, and the drug resistance of the inductions such as existing medicine Gefitinib, Tarceva can be overcome. 。 |
| priorityDate | 2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 552.